A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

Completed · Phase 1

Conditions studied: Healthy, Narcolepsy

In brief

The goal of this study is to learn what happens to MK-6552 in a person's body over time. Researchers will compare what happens to levels of MK-6552 in people's blood when it is taken with and without modafinil. Researchers also want to learn about the safety of MK-6552 taken with and without modafinil and if people tolerate it.

Key facts

Study ID

NCT06665230

Run by

Merck Sharp & Dohme LLC

People needed

12

Starts

2023-09-20

Expected to finish

2023-11-20

Last updated by the study team

2024-10-30

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• The main inclusion criteria include but are not limited to the following:
• Is in good health based on medical history and physical examination
• Has a body mass index ≥18 and ≤32 kg/m\^2, inclusive

You may not qualify if…

• The main exclusion criteria include but are not limited to the following:
• Has a history of clinically significant endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases
• Has a history of cancer

Where it is running

• Alliance for Multispecialty Research, LLC (Site 0001) — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.